Protective action of cyclandelate in hypoxia.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001921:Brain / Q000503:physiopathology; D002250:Carbon Radioisotopes; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use*; D004569:Electroencephalography; D005947:Glucose / Q000378:metabolism; D000860:Hypoxia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D007274:Injections, Intraperitoneal; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D009584:Nitrogen; D009609:Nitrous Oxide; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003510:Cyclohexanes; D008333:Mandelic Acids; D014665:Vasodilator Agents; D005947:Glucose; D009609:Nitrous Oxide; D009584:Nitrogen